▪▪▪

We read with great interest the recent publication by La Mura et  al1 that focused on the potential beneficial role of anticoagulants in the treatment of portal vein thrombosis (PVT) in cirrhotic patients. The investigators concluded that anticoagulant therapy (VKA) is highly effective in portal recanalization, without any evidence of an increased risk of bleedi ng, compared with untreated cirrhotic patients. In addition, La Mura et al1 successfully showed that achieving a complete recanalization of PVT with VKA is associated with a significant reduction in the long-term risk of PTH-related complication and death and/or need for a liver transplant.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research